Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
ClinicalTrials.gov study NCT05124288. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02899286. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01198054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05577611. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01455025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation
ClinicalTrials.gov study NCT04203316. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01904643. IPD Sharing: NO. Countries: 1. Publications: 0.
TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts
ClinicalTrials.gov study NCT03816319. IPD Sharing: YES. Countries: 2. Publications: 0.
Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00096148. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04920188. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01055483. IPD Sharing: Not stated. Countries: 2. Publications: 0.
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06746519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06763341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06445907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.
ClinicalTrials.gov study NCT03350152. IPD Sharing: NO. Countries: 1. Publications: 0.
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT03311815. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04774744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Imaging to Capture Disease Heterogeneity in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02682732. IPD Sharing: NO. Countries: 1. Publications: 0.
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07022678. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia
ClinicalTrials.gov study NCT00838240. IPD Sharing: Not stated. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.